Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube Cancer - Contacts and Locations

Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube Cancer

This study has been completed.

Study NCT00003385. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00003385

Locations


United States, Hawaii
	MBCCOP - Hawaii
	Honolulu, Hawaii, United States, 96813

United States, Iowa
	Holden Comprehensive Cancer Center
	Iowa City, Iowa, United States, 52242-1009

United States, Maryland
	Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support
	Bethesda, Maryland, United States, 20892-1182

United States, Ohio
	Cleveland Clinic Taussig Cancer Center
	Cleveland, Ohio, United States, 44195
	Ireland Cancer Center
	Cleveland, Ohio, United States, 44106

United States, Texas
	University of Texas Medical Branch
	Galveston, Texas, United States, 77555-0587

United States, Washington
	Fred Hutchinson Cancer Research Center
	Seattle, Washington, United States, 98109-1024

Norway
	Norwegian Radium Hospital
	Oslo, Norway, N-0310

Sponsors and Collaborators

Gynecologic Oncology Group

National Cancer Institute (NCI)

Investigators


Study Chair:	Peter G. Rose, MD	MetroHealth Cancer Care Center at MetroHealth Medical Center